Episode Description
In this episode, Tom Hickey, Director of Therapeutic Strategy at Novotech, explores the rapidly evolving world of RNA therapeutics. From the rise of mRNA vaccines to new delivery technologies like lipid nanoparticles, Tom shares where he sees the biggest opportunities and challenges for biotech companies today.
Tune in to hear practical insights on building strong partnerships, accessing global patient populations, and what’s next for RNA-based therapies as they move into more common disease areas.
To learn how Novotech’s deep regional expertise and trusted partnerships help biotech and pharma sponsors advance novel RNA programs with confidence, contact one of our experts: